Wave Life Sciences (WVE) Change in Account Payables (2016 - 2026)
Wave Life Sciences (WVE) has disclosed Change in Account Payables for 12 consecutive years, with $3.3 million as the latest value for Q1 2026.
- For Q1 2026, Change in Account Payables rose 260.28% year-over-year to $3.3 million; the TTM value through Mar 2026 reached $4.8 million, up 96.14%, while the annual FY2025 figure was -$561000.0, 116.4% down from the prior year.
- Change in Account Payables hit $3.3 million in Q1 2026 for Wave Life Sciences, up from $1.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.1 million in Q2 2024 and bottomed at -$5.1 million in Q3 2024.
- Average Change in Account Payables over 5 years is $690352.9, with a median of $503000.0 recorded in 2023.
- On a YoY basis, Change in Account Payables climbed as much as 2701.38% in 2024 and fell as far as 1109.54% in 2024.
- Wave Life Sciences' Change in Account Payables stood at $1.0 million in 2022, then plummeted by 81.01% to $192000.0 in 2023, then soared by 1702.08% to $3.5 million in 2024, then plummeted by 66.59% to $1.2 million in 2025, then skyrocketed by 184.52% to $3.3 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods came in at $3.3 million, $1.2 million, and $59000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.